Efficacy and safety of temafloxacin versus those of amoxicillin in hospitalized adults with community-acquired pneumonia.

Temafloxacin, a new fluoroquinolone, was compared with amoxicillin in the treatment of adult hospitalized patients with community-acquired pneumonia. In this double-blind, multicenter study, patients were randomly assigned to treatment with temafloxacin at 600 mg twice daily (n = 125) or amoxicillin...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Carbon, C, Léophonte, P, Petitpretz, P, Chauvin, J P, Hazebroucq, J
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1992
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC189443/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1323954/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.36.4.833
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!